medigraphic.com
Colegio de Medicina Interna de México.

2016, Number 2

<< Back Next >>

Med Int Mex 2016; 32 (2)

Diffuse alveolar hemorrhage: frequency, cause and outcome

Rodríguez-Chagolla JM, Gutiérrez-Bernal J, García-Alcalá MC, Estrada-Castro E, García-Nava M, Rivero-Navarro MÁ, Meléndez-Mercado C, Valdespino-Vázquez MY, Mateos-Toledo H

Language: Spanish
References: 23
Page: 169-175
PDF size: 592.43 Kb.


ABSTRACT

Background: Diffuse alveolar hemorrhage (DAH) is a clinical pathological syndrome that describes the presence of erythrocytes in the alveolar space; these are originated from pulmonary capillarity.
Objetive: To describe the frequency, etiology and outcome of DAH in the ISSEMyM Hospital Center, Toluca, Mexico.
Material and Method: A descriptive and retrospective study was done based on the review of medical records from March 2008 to March 2013 to classify the DAH cases according to current criterion.
Results: Fifteen cases of DAH were identified. The main causes were autoimmune diseases: 40% lupus erythematosus (LES) and 40% ANCA’s associated vasculitis (AAV); 46% of patients were admitted to intensive care unit, and they required invasive mechanical ventilation (IMV), with an average stay of ten days and mortality of 20%.
Conclusion: The main causes of DAH were autoimmune diseases (in the same proportion LES-AAV), showing a mortality of 20%. The only association with death was the IMV necessity.


REFERENCES

  1. Buendía-Roldán I, Navarro C, Rojas-Serrano J. Hemorragia alveolar difusa: causas y desenlaces en un instituto de tercer nivel. Reumatol Clin 2010;6:196-198.

  2. Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med 2008;75:258, 260, 264-255.

  3. De Prost N, et al. Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med 2012;106:1021-1032.

  4. West Stephen , Arulkumaran N, Ind PW, Pusey CD. Diffuse alveolar haemorrhage in ANCA-associated vasculitis. Intern Med 2013;52:5-13.

  5. Benoit FL, Rulon CB, Theil GB, Doolan PD, Watten RH. Goodpasture’s syndrome: a clinicopathologic entity. Am J Med 1964;37:424-444.

  6. Zamora MR , Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76:192-202.

  7. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004;25:583-592.

  8. Gómez-Román JJ. Hemorragias alveolares difusas pulmonares. Arch Bronconeumol 2008;44:428-436.

  9. Corrin B, Nicholson A. Pathology of the lung. 3rd ed. Churchill Livingston Elsevier, 2011;135-153.

  10. Lara AR, Frankel SK, Schwarz MI. Diffuse alveolar hemorrhage. In: Interstitial lung disease. Schwarz MI, King TE Jr (eds). 5th ed. Shelton: People’s Medical Publishing House, 2011;805.

  11. Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14:1112-1125.

  12. Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest 2010;137:1164-1171.

  13. Ioachimescu OC, et al. Diffuse alveolar hemorrhage: diagnosis it and finding the cause. Cleve Clinic J Med 2008:75:258-280.

  14. Park MS. Diffuse alveolar hemorrhage. Tuberc Respir Dis 2013;74:151-162.

  15. Kostianovsky A, Hauser T, Pagnoux C, et al. Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients’ features and prognostic factors. Clin Exp Rheumatol 2012;30:77-82.

  16. Schreiber J, Knolle J, Kachel R, Schück R. Differential diagnosis of diffuse pulmonary haemorrhage. Pneumologie 2006;60:347-354.

  17. Martínez-Martínez MU, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus 2011;20:568-574.

  18. Martínez-Martínez MU, Abud-Mendoza C. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis. Reumatol Clin 2014;10:248-253.

  19. Barile LA, Jara LJ, Medina-Rodriguez F, Garcia-Figueroa J, Miranda-Limon J. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 1997;6:445-448.

  20. Sneller MC. Wegener ’s granulomatosis. JAMA 1995:273:1288-1291.

  21. Lynch JP, White E, Tazelaar H, et al. Wegener’s granulomatosis: evolving concepts in treatment. Semin Respir Crit Care Med 2004;25:491-521.

  22. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.

  23. Haworth SJ, Savage CO, Carr D, Hughes JM, Rees AJ. Pulmonary haemorrhage complicating Wegener’s granulomatosis and microscopic polyarteritis. Br Med J (Clin Res Ed) 1985;290:1775-1778.




2020     |     www.medigraphic.com